Biomedical Engineering Reference
In-Depth Information
Cirone, P. and J.M. Bourgeois, F. Shen, and P.L. Chang. 2004. Combined immunotherapy
and antiangiogenic therapy of cancer with microencapsulated cells. Hum. Gene h er.
15(10): 945-959.
Clark, R. and T. Kupper. 2005. Old meets new: the interaction between innate and adaptive
immunity. J. Invest. Dermatol. 125(4): 629-637.
Clark, R.A. and B. Chong, N. Mirchandani, N.K. Brinster, K. Yamanaka, R.K. Dowgiert,
and T.S. Kupper. 2006. h e vast majority of CLA+ T cells are resident in normal skin. J.
Immunol. 176(7): 4431-4439.
Clark, R.A. and S.J. Huang, G.F. Murphy, I.G. Mollet, D. Hijnen, M. Muthukuru, C.F.
Schanbacher, V. Edwards, D.M. Miller, J.E. Kim, J. Lambert, and T.S. Kupper. 2008.
Human squamous cell carcinomas evade the immune response by down-regulation of
vascular E-selectin and recruitment of regulatory T cells. J. Exp. Med. 205(10): 2221-
2234.
Dimitrof , C.J. and J.Y. Lee, S. Rai i, R.C. Fuhlbrigge, and R. Sackstein. 2001. CD44 is a
major E-selectin ligand on human hematopoietic progenitor cells. J. Cell Biol. 153(6):
1277-1286.
Dirkx, A.E. and M.G. Oude Egbrink, M.J. Kuijpers, S.T. van der Niet, V.V. Heijnen, J.C.
Bouma-ter Steege, J. Wagstaf , and A.W. Grii oen. 2003. Tumor angiogenesis modulates
leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule
expression. Cancer Res. 63(9): 2322-2329.
Ebert, L.M. and S. Meuter, and B. Moser. 2006. Homing and function of human skin
gammadelta T cells and NK cells: relevance for tumor surveillance. J. Immunol. 176(7):
4331-4336.
Edele, F. and R. Molenaar, D. Gutle, J.C. Dudda, T. Jakob, B. Homey, R. Mebius, M. Hornef,
and S.F. Martin. 2008. Cutting edge: instructive role of peripheral tissue cells in the
imprinting of T cell homing receptor patterns. J. Immunol. 181(6): 3745-3749.
Fitzhugh, D.J. and S. Naik, S.W. Caughman, and S.T. Hwang. 2000. Cutting edge: C-C
chemokine receptor 6 is essential for arrest of a subset of memory T cells on activated
dermal microvascular endothelial cells under physiologic l ow conditions in vitro. J.
Immunol. 165(12): 6677-6681.
Fuhlbrigge, R.C. and J.D. Kief er, D. Armerding, and T.S. Kupper. 1997. Cutaneous
lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells.
Nature 389(6654): 978-981.
Fuhlbrigge, R.C. and S.L. King, R. Sackstein, and T.S. Kupper. 2006. CD43 is a ligand for
E-selectin on CLA+ human T cells. Blood 107(4): 1421-1426.
Fuhlbrigge, R.C. and C. Weishaupt. 2007. Adhesion molecules in cutaneous immunity.
Seminars in Immunopathology 29(1): 45-57.
Ganss, R. and B. Arnold, and G.J. Hammerling. 2004. Mini-review: overcoming tumor-
intrinsic resistance to immune ef ector function. Eur. J. Immunol. 34(10): 2635-2641.
Grii oen, A.W. 2008. Anti-angiogenesis: making the tumor vulnerable to the immune
system. Cancer Immunol. Immunother. 57(10): 1553-1558.
Kupper, T.S. and R.C. Fuhlbrigge. 2004. Immune surveillance in the skin: mechanisms and
clinical consequences. Nat. Rev. Immunol. 4(3): 211-222.
